Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-07-01 Menzel Garry E Director Grant or award · Option to purchase Ordinary Shares +1,121,604 1,121,604
2023-07-10 Menzel Garry E Director Sale −47,702 $0.91 $43K 75,056
2023-07-05 Menzel Garry E Director Grant or award · Option to Purchase Ordinary Shares +736,548 736,548
2023-07-05 Menzel Garry E Director Grant or award · Option to Purchase Ordinary Shares +1,251,966 1,251,966
2023-07-05 Menzel Garry E Director Grant or award · Option to Purchase Ordinary Shares +359,700 359,700
2023-07-05 Menzel Garry E Director Grant or award · Option to Purchase Ordinary Shares +3,568,026 3,568,026
2023-07-05 Menzel Garry E Director Grant or award · Option to Purchase Ordinary Shares +57,846 57,846
2023-07-05 Menzel Garry E Director Grant or award · Option to Purchase Ordinary Shares +2,715,816 2,715,816
2023-07-05 Menzel Garry E Director Grant or award · Option to Purchase Ordinary Shares +2,158,776 2,158,776
2023-07-03 Menzel Garry E Director Grant or award · Option to purchase Ordinary Shares +981,463 981,463
2023-06-01 Menzel Garry E Director Grant or award +200,646 200,646
2023-06-01 Menzel Garry E Director Grant or award +200,647 200,647
2023-06-01 Menzel Garry E Director Grant or award +209,931 209,931

Page 1 of 1 · 13 trades